news CRISPR-Cas9 used to prevent Fuchs’ corneal dystrophy in mice 4 August 2021 | By Anna Begley (Drug Target Review) Scientists have shown that start codon disruption with CRISPR-Cas9 gene editing can prevent Fuchs’ corneal dystrophy in mouse models.
news Full gene-replacement model developed for Alzheimer’s MAPT gene research 17 October 2019 | By Drug Target Review Researchers in the US have successfully produced a mouse model with a human MAPT gene to enable more accurate research into Alzheimer’s therapy.
news 130 new treatments for corneal disorders but cause still not yet known 21 September 2016 | By Niamh Louise Marriott, Digital Content Producer The potential to help thousands of people with eye conditions. However the report reveals a lack of developments for the cause of sight loss in corneal...